BSECompany Update23 Jul 2026 · 23 Jul 2026, 02:54 pm

Further investment in Medcuore Medical Solutions Private Limited

Indo National Ltd · 504058

✦ AI SummaryExpansion

Indo National Ltd has invested Rs. 49,93,872 in Medcuore Medical Solutions Private Ltd, acquiring an additional 0.75% equity stake, taking its total shareholding to 61.09%. The investment is aimed at facilitating business growth and generating revenue.

Analysis Scores

Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Indo National Ltd - 504058 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

Attachments (1)

📄

c71b7c36-226d-4374-8db5-792046b4546c.pdf

pdf

Download →
View document text
23rd July 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, "Exchange Plaza", 5th Floor, Dalal Street, Fort, Plot No. C/1, G Block Bandra-Kurla Complex Mumbai 400 001 Bandra (East), Mumbai 400 051 Scrip code: 504058 NSE SYMBOL: NIPPOBATRY Dear Sir/Madam, Sub: Intimation under Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR”), as amended read with the Securities and Exchange Board of India (“SEBI”) master circular dated November 11, 2024, bearing reference no. SEBI/HO/CFD/PoD2/CIR/P/0155 (“SEBI Circular”) Pursuant to the provisions of Regulation 30 of the SEBI LODR, we would like to inform that the Company has invested an aggregate amount of Rs. 49,93,872 (Rupees Forty-Nine Lakh Ninety-Three Thousand Eight Hundred and Seventy-Two only), by way of subscription to Equity Shares of Medcuore Medical Solutions Private Ltd (“MMSPL”). The said investment represents an additional 0.75% of the paid-up share capital in MMSPL on a fully diluted basis. The disclosure required under Schedule III of the SEBI LODR read with the SEBI Circular, is enclosed herewith as Annexure-A. Kindly take the above on your record. For Indo National Limited J. Srinivasan Company Secretary lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034. Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006. CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in ANNEXURE – A Disclosure of information as required under SEBI circular are as follows:- Particulars Details 1. name of the target entity, details Name: Medcuore Medical Solutions Private Ltd in brief such as size, turnover etc.; Turnover (FY 25-26): Rs. 1,45,60,000 2. whether the acquisition would Pursuant to an additional primary investment of fall within related party Rs. 49,93,872, the Company has acquired a transaction(s) and whether the further 0.75% equity stake in MMSPL. Following promoter/ promoter group/ this acquisition, the Company’s aggregate group companies have any shareholding in MMSPL now stands at 61.09%. interest in the entity being The acquisition would not fall under related acquired? If yes, nature of party transaction. None of the promoter/ interest and details thereof and promoter group/ group companies have any whether the same is done at interest in the entity being acquired. “arm’s length” 3. Industry to which the entity MMSPL is engaged in the business of being acquired belongs manufacturing, distribution and providing services in relation to Air Monitoring System and Air Purifiers. 4. objects and impact of acquisition Object and impact: To facilitate business growth (including but not limited to, and to generate revenue and to earn profit due disclosure of reasons for to expansion of business acquisition of target entity, if its business is outside the main line of business of the listed entity); 5. brief details of any governmental Nil or regulatory approvals required for the acquisition; 6. Indicative time period for Upto FY 2027-28 completion of the acquisition lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034. Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006. CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in Particulars Details 7. Consideration- whether cash Cash consideration consideration or share swap or any other form and details of the same. 8. Cost of acquisition and/or the The shares were acquired based on valuation price at which the shares are report issued by registered valuer. The price per acquired; share is Rs. 16,536/- (Rupees Sixteen thousand five hundred and thirty six). 9. Percentage of shareholding / An additional 0.75% of the paid-up share capital control acquired and / or number in MMSPL has been acquired, taking the of shares acquired Company’s total shareholding to 61.09%. Number of shares acquired: 302 shares 10. Brief background about the a. Name: Medcuore Medical Solutions Private entity acquired in terms of Ltd products/line of business acquired, date of incorporation, b. Product and Line of Business: business of history of last 3 years turnover, manufacturing, distribution and providing country in which the acquired services in relation to Air Monitoring System and entity has presence and any Air Purifiers. other significant information (in c. Date of Incorporation: 07/06/2020 brief) d. Last 3 years turnover: FY 26 Rs. 1,45,60,000 FY 25 Rs. 35,41,484 FY24 Rs. 47,68,000 e. country in which the acquired entity has presence: India lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034. Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006. CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in